Expression and function of phosphoinositide 3-kinase delta in mesenchymal stromal cells from normal and leukaemic bone marrow

Br J Haematol. 2019 Jun;185(5):883-887. doi: 10.1111/bjh.15865. Epub 2019 Mar 14.


Within lymphoid tissues, chronic lymphocytic leukaemia (CLL) cells interact with mesenchymal stromal cells (MSC). Inhibitors of phosphoinositide 3-kinase delta (PI3Kδ) cause release of CLL cells from lymphoid tissues into blood. PI3Kδ inhibitors are thought to target only CLL and other immune cells because PI3Kδ expression is restricted to haematopoietic cells. We found that PI3Kδ is unexpectedly expressed in primary MSC derived from CLL patients and healthy donors. PI3Kδ inhibition in MSC using idelalisib or duvelisib significantly reduced their ability to support CLL migration and adhesion. These observations provide the first evidence that PI3Kδ is expressed and functional in CLL MSC.

Keywords: cell adhesion; cell signalling; chemotaxis; chronic lymphocytic leukaemia; stromal cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Bone Marrow Cells / enzymology*
  • Bone Marrow Cells / pathology
  • Case-Control Studies
  • Class I Phosphatidylinositol 3-Kinases / antagonists & inhibitors
  • Class I Phosphatidylinositol 3-Kinases / biosynthesis
  • Class I Phosphatidylinositol 3-Kinases / genetics
  • Class I Phosphatidylinositol 3-Kinases / metabolism*
  • Enzyme Inhibitors / pharmacology
  • HEK293 Cells
  • Humans
  • Isoquinolines / pharmacology
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell / enzymology*
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology
  • Mesenchymal Stem Cells / enzymology*
  • Mesenchymal Stem Cells / pathology
  • Purines / pharmacology
  • Quinazolinones / pharmacology


  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Isoquinolines
  • Purines
  • Quinazolinones
  • duvelisib
  • Class I Phosphatidylinositol 3-Kinases
  • PIK3CD protein, human
  • idelalisib